These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 17009252)
21. Pad test by mail for home evaluation of urinary incontinence. Flisser AJ; Figueroa J; Bleustein CB; Panagopoulos G; Blaivas JG Neurourol Urodyn; 2004; 23(2):127-9. PubMed ID: 14983423 [TBL] [Abstract][Full Text] [Related]
22. Are there differences between women with urge predominant and stress predominant mixed urinary incontinence? Lewis JB; Ng AV; O'Connor RC; Guralnick ML Neurourol Urodyn; 2007; 26(2):204-7. PubMed ID: 17078089 [TBL] [Abstract][Full Text] [Related]
23. Sacral nerve stimulation is more effective than optimal medical therapy for severe fecal incontinence: a randomized, controlled study. Tjandra JJ; Chan MK; Yeh CH; Murray-Green C Dis Colon Rectum; 2008 May; 51(5):494-502. PubMed ID: 18278532 [TBL] [Abstract][Full Text] [Related]
25. Do pad tests and voiding diaries affect patient willingness to participate in studies of incontinence treatment outcomes? Singh M; Bushman W; Clemens JQ J Urol; 2004 Jan; 171(1):316-8; discussion 318-9. PubMed ID: 14665904 [TBL] [Abstract][Full Text] [Related]
28. Patient-centered surgical outcomes: the impact of goal achievement and urge incontinence on patient satisfaction one year after surgery. Mahajan ST; Elkadry EA; Kenton KS; Shott S; Brubaker L Am J Obstet Gynecol; 2006 Mar; 194(3):722-8. PubMed ID: 16522404 [TBL] [Abstract][Full Text] [Related]
29. Sacral neuromodulation for the treatment of refractory urinary urge incontinence after stress incontinence surgery. Sherman ND; Jamison MG; Webster GD; Amundsen CL Am J Obstet Gynecol; 2005 Dec; 193(6):2083-7. PubMed ID: 16325620 [TBL] [Abstract][Full Text] [Related]
30. One year follow-up on the SPARC sling system for the treatment of female urodynamic stress incontinence. Primus G Int J Urol; 2006 Nov; 13(11):1410-4. PubMed ID: 17083393 [TBL] [Abstract][Full Text] [Related]
31. Electromotive drug-administration: a pilot study for minimal-invasive treatment of therapy-resistant idiopathic detrusor overactivity. Bach P; Wormland RT; Möhring C; Goepel M Neurourol Urodyn; 2009; 28(3):209-13. PubMed ID: 19205067 [TBL] [Abstract][Full Text] [Related]
33. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues. Cady R; Schreiber C Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501 [TBL] [Abstract][Full Text] [Related]
35. Chronic sacral neuromodulation in patients with lower urinary tract symptoms: results from a national register. Spinelli M; Bertapelle P; Cappellano F; Zanollo A; Carone R; Catanzaro F; Giardiello G; De Seta F; J Urol; 2001 Aug; 166(2):541-5. PubMed ID: 11458063 [TBL] [Abstract][Full Text] [Related]
36. A statistical comparison of pad numbers versus pad weights in the quantification of urinary incontinence. Dylewski DA; Jamison MG; Borawski KM; Sherman ND; Amundsen CL; Webster GD Neurourol Urodyn; 2007; 26(1):3-7. PubMed ID: 17080415 [TBL] [Abstract][Full Text] [Related]